DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Fonebox Retail Limited — Key licenses/regulatory approvals (Sub-para 12-Para B)

NSE 1 hr ago·9 Oct 2026, 9:38 am

Fonebox Retail

Fonebox Retail Limited has informed stock exchanges about the receipt of certain key licenses and regulatory approvals. This development is a significant milestone for the company, as it clears a major hurdle for its business operations and future growth.

For investors, this news is positive as it removes regulatory uncertainty and paves the way for the company to execute its strategic plans. It signals a maturation of the business and could lead to improved operational efficiency and profitability in the coming quarters.

Investors should monitor the company's future announcements to understand how these approvals will be utilized. Keeping an eye on the company's operational performance and any further regulatory filings will provide more clarity on the impact of these approvals.